Hydreight Technologies Inc NURS
TSXV · Canada · Retail Trade
CAD 3.27-0.06 (-1.80%)
Market closed· · CAD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · CAD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Company posts $28 million in quarterly revenue and reaffirms $150 million full-year guidance amid expanding direct-to-consumer platform and new peptide opportunities.
Hydreight Technologies Inc. ("Hydreight" or the "Company") (TSXV: NURS) (OTCQB: HYDTF) (FSE: SO6), a U.S.-focused digital health infrastructure platform, is pleased to report its financial results for the three and six months ended June 30, 2026. All figures are in Canadian dollars unless otherwise stated.
Hydreight Technologies Inc. ("Hydreight" or the "Company") (TSXV: NURS) (OTCQB: HYDTF) (FSE: SO6), a rapidly growing digital health platform and provider of compliant healthcare infrastructure across the United States, today announced that the Company will release its second quarter 2026 financial results after market close on Monday, August 31, 2026.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.